4
Changes in Ownership
Vericel Corp Filed Acc 0001140361-24-003663
Director sold 8,000 shares at an average $41.85 ($334,775)
- Director acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZERBE ROBERT L MD Director | 2024-01-22 | Sale 10b5-1 | −2,500 | $41.39 | $103,475 | 28,395 | D |
| ZERBE ROBERT L MD Director | 2024-01-22 | Sale 10b5-1 | −2,500 | $42.06 | $105,150 | 25,895 | D |
| ZERBE ROBERT L MD Director | 2024-01-22 | Option exercise 10b5-1 | +3,000 | $4.12 | $12,360 | 28,895 | D |
| ZERBE ROBERT L MD Director | 2024-01-22 | Sale 10b5-1 | −3,000 | $42.05 | $126,150 | 25,895 | D |
| Derivatives | |||||||
| ZERBE ROBERT L MD Director | 2024-01-22 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +3,000 | 0 | D | ||
| Open-market sales · 8,000 sh · avg $41.85 · $334,775 | |||||||
Loading xslF345X05/form4.xml…